Three Factors Can ID Conservative Treatment Response in Meniere Disease
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Oct. 4, 2023 -- A clinical severity staging system has been developed that can identify treatment response for patients with Meniere disease, according to a study published online Aug. 25 in Otolaryngology-Head & Neck Surgery.
Brevin J. Miller, from the Washington University School of Medicine in St. Louis, and colleagues conducted a retrospective cohort study involving adult patients newly diagnosed with Meniere disease between Jan. 1, 2016, and Dec. 31, 2019, at a tertiary academic medical center to identify clinically important factors associated with conservative treatment response.
The researchers found that 63 and 37 percent of the 78 patients included in the study were responsive and not responsive to conservative therapies, respectively. Compared with unresponsive patients, responsive patients had higher proportions of no or mild vertigo and none or mild comorbidity and a lower proportion of hearing loss. A three-stage system was developed by performing conjunctive consolidation of these factors, with a treatment response gradient varying from 100 to 64 to 18 percent for stages 1, 2, and 3, respectively.
"This study identifies less severe vertigo, absence of hearing loss, and low comorbidity burden as clinically meaningful and readily available factors associated with conservative treatment response in patients with Meniere disease," the authors write. "The development of a composite clinical severity staging system using these factors provides novel insight regarding therapeutic response."
One author is a consultant for Cochlear Ltd.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
Breakthrough Gene Therapy Enables Infant Born Deaf to Hear
FRIDAY, May 10, 2024 -- Significant hearing improvements have been achieved in an infant with profound hearing loss due to a biallelic otoferlin gene (OTOF) mutation, according to...
Clinical Practice Guideline Developed for Age-Related Hearing Loss
FRIDAY, May 10, 2024 -- In a clinical practice guideline issued by the American Academy of Otolaryngology-Head and Neck Surgery Foundation and published online April 30 in...
Study Compares Vestibular Endolymphatic Hydrops Grading Methods in Meniere Disease
TUESDAY, May 7, 2024 -- In a study published online April 17 in the European Archives of Oto-Rhino-Laryngology, different grading methods for vestibular endolymphatic hydrops (EH)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.